Phase II Study of Dabrafenib and Trametinib in Patients With Tumors With BRAF(V600E) Mutations: Updated Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol H
达拉非尼和曲美替尼治疗BRAF(V600E)突变肿瘤患者的II期研究:NCI-MATCH ECOG-ACRIN试验(EAY131)子方案H的最新结果
期刊:Jco Precision Oncology
影响因子:5.6
doi:10.1200/PO-25-00338
Salama, April K S; Wang, Victoria; Macrae, Erin R; Park, Jong-In; Chen, Helen X; Gray, Robert J; McShane, Lisa M; Rubinstein, Larry V; Patton, David; Williams, P Mickey; Hamilton, Stanley R; Armstrong, Deborah K; Tricoli, James V; Conley, Barbara A; Arteaga, Carlos L; Harris, Lyndsay N; O'Dwyer, Peter J; Chen, Alice P; Flaherty, Keith T